Lazard Asset Management’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-45,398
Closed -$372K 2235
2025
Q2
$372K Buy
+45,398
New +$380K ﹤0.01% 1572
2025
Q1
Sell
-45
Closed 2538
2024
Q4
$0 Sell
45
-7,585
-99% -$71.2K ﹤0.01% 2493
2024
Q3
$80K Buy
7,630
+7,511
+6,312% +$91.6K ﹤0.01% 1826
2024
Q2
$0 Sell
119
-1,652
-93% -$25.7K ﹤0.01% 2394
2024
Q1
$36K Sell
1,771
-9,736
-85% -$173K ﹤0.01% 1786
2023
Q4
$205K Buy
11,507
+8,917
+344% +$157K ﹤0.01% 1372
2023
Q3
$41K Buy
2,590
+107
+4% +$1.94K ﹤0.01% 1910
2023
Q2
$48K Sell
2,483
-3,631
-59% -$70K ﹤0.01% 1846
2023
Q1
$114K Sell
6,114
-3,110
-34% -$68.8K ﹤0.01% 1483
2022
Q4
$208K Sell
9,224
-1,027
-10% -$23.2K ﹤0.01% 1293
2022
Q3
$270K Buy
10,251
+505
+5% +$15K ﹤0.01% 1209
2022
Q2
$240K Buy
9,746
+3,158
+48% +$78.9K ﹤0.01% 1233
2022
Q1
$218K Buy
6,588
+4,548
+223% +$126K ﹤0.01% 1238
2021
Q4
$66K Sell
2,040
-1,799
-47% -$61.3K ﹤0.01% 1620
2021
Q3
$160K Buy
3,839
+1,293
+51% +$46.5K ﹤0.01% 1324
2021
Q2
$98K Buy
2,546
+2,494
+4,796% +$89.2K ﹤0.01% 1347
2021
Q1
$1K Sell
52
-1,707
-97% -$72.8K ﹤0.01% 1827
2020
Q4
$79K Buy
1,759
+356
+25% +$12.4K ﹤0.01% 1237
2020
Q3
$38K Sell
1,403
-569
-29% -$18.6K ﹤0.01% 1270
2020
Q2
$72K Buy
+1,972
New +$73.5K ﹤0.01% 1109
2020
Q1
Sell
-1,496
Closed -$61K 1714
2019
Q4
$61K Buy
+1,496
New +$59.1K ﹤0.01% 1018
2018
Q3
Sell
-18,932
Closed -$1.36M 1097
2018
Q2
$1.36M Buy
+18,932
New +$904K ﹤0.01% 703

Other funds holding RGNX